Skip to main content

ADRENALINE-LINK 1:10,000 1 mg/10 mL adrenaline (epinephrine) acid tartrate injection BP pre filled syringe, Link Pharmaceuticals, CON-220

Product name
ADRENALINE-LINK 1:10,000 1 mg/10 mL adrenaline (epinephrine) acid tartrate injection BP pre filled syringe
Sponsor name
Link Pharmaceuticals
Consent start
Consent no.
CON-220
Standard
Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines.
Non-compliance with standard
Do not bear the Australian name of the medicine (paragraphs 8(1)(a), 9(1)(a) and 10(4)(c) of TGO 91). Do not have the name of the medicine and the name and quantity of the active ingredient displayed as a 'cohesive unit' on the main label as detailed in subections 9(2) and 9(3) of TGO 91. Do not bear the approved route of administration (paragraphs 8(1)(m), 9(1)(f) and 10(4)(k) of TGO 91). Do not bear the statements 'Use in one patient on one occasion only. Contains no antimicrobial preservative' (paragraph 10(3)(b) of TGO 91). Do not have the name of the medicine displayed on at least three non-opposing sides of the carton (paragraph 8(1)(o) of TGO 91). The UK carton label does not express the name and quantity of each excipient in the medicine (paragraph 10(3)(a) of TGO 91). The label for the prefilled syringe does not bear the name or registered trademark of the Australian sponsor or the Australian distributor (paragraph 10(4)(j) of TGO 91).
Conditions imposed
          A 'Dear Healthcare Professional letter identical to that provided to the Therapeutic Goods Administration on 25 October 2017 will be supplied with the affected product, informing that the product is packaged with UK labelling and advising the Healthcare Professionals of the differences between the UK labelling, including packaging insert, and the Australian approved product. In particular, that this product is for intravenous use only.       The labels (i.e. UK carton, carton closure and prefilled syringe labels) to which this consent applies are those provided with the letter of application, where the carton label includes an over-sticker that details the Australian sponsor's name and contact details (address, phone, fax and email), and the AUST R number.      
Therapeutic product type
Prescription medicines

Help us improve the Therapeutic Goods Administration site